FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

411531001: Short-acting insulin (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2466982015 Short-acting insulin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2473144019 Short-acting insulin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3199471000005119 korttidsvirkende insulin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    korttidsvirkende insulin Is a Insulin false Inferred relationship Some
    korttidsvirkende insulin This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Pancreatic hormone (disposition) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Regular insulin (substance) Is a False korttidsvirkende insulin Inferred relationship Some
    opløseligt humant insulin 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    opløseligt humant insulin 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    insulin lispro 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    insulin lispro 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    insulin lispro 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    opløseligt humant insulin 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    korttidsvirkende insulin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some 1
    Product containing insulin lispro and insulin lispro protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    opløseligt bovint insulin 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    opløseligt bovint insulin 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    opløseligt porcint insulin 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    opløseligt porcint insulin 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk insulin lispro 25/75 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 40/60 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 40/60 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 40/60 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 25/75 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 25/75 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 25/75 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk insulin lispro 25/75 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    opløseligt humant insulin 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    opløseligt humant insulin 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    insulin lispro 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk porcint insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk porcint insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    hurtigtvirkende zinkinsulin Is a False korttidsvirkende insulin Inferred relationship Some
    Insulin glulisine (substance) Is a False korttidsvirkende insulin Inferred relationship Some
    insulin aspart 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    insulin aspart 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk insulin aspart 30/70 100 enheder/ml injektionsvæske, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk insulin aspart 30/70 100 enheder/ml injektionsvæske i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    Product containing insulin aspart (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    Product containing insulin lispro (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    Human insulin soluble-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    Porcine insulin soluble-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    Bovine insulin soluble-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk insulinprodukt The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk porcint insulin isofan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk insulin lispro The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    insulin aspart (rekombinant human insulinanalog) 100 enheder/ml injektionsvæske, opløsning, fyldt injektionsudstyr til engangsbrug The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, 3 ml fyldt injektionsudstyr til engangsbrug The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    opløseligt bovint insulin 100 enheder/ml injektionsvæske, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    opløseligt bovint insulin 100 enheder/ml injektionsvæske, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    bifasisk insulin aspart 30 og 70 100 enheder/ml, opløsning til injektion, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False korttidsvirkende insulin Inferred relationship Some
    Insulin aspart Is a False korttidsvirkende insulin Inferred relationship Some
    Insulin lispro Is a False korttidsvirkende insulin Inferred relationship Some
    Insulin aspart protamine (substance) Is a False korttidsvirkende insulin Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start